"Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review"

Pituitary. 2024 Oct;27(5):455-467. doi: 10.1007/s11102-024-01441-9. Epub 2024 Aug 14.

Abstract

Purpose: This study investigates the rare occurrence of tumor-to-tumor metastasis in Pituitary Neuroendocrine Tumors (PitNETs), also known as pituitary adenomas, aiming to enhance understanding of its diagnostic and therapeutic challenges. We report two cases from our institution of tumor-to-tumor metastasis involving PitNETs, followed by a systematic literature review.

Methods: We conducted a comprehensive literature review using PubMed and Google Scholar databases. This review provides insights into patient demographics, clinical presentations, primary tumor origin, management approaches and outcomes.

Results: We identified 38 documented cases of tumor-to-tumor metastasis involving the pituitary gland in the literature. This revealed a diverse range of primary tumor origins, with lung, breast, and renal carcinomas being the most prevalent. Clinical presentations varied, with visual disturbances emerging as the most frequently reported symptom. Surgical interventions predominantly resulted in subtotal resection. Kaplan-Meier survival analysis demonstrated that endoscopic endonasal approaches (EEA) are associated with longer median survival times compared to other surgical methods.

Conclusion: Tumor-to-tumor metastasis to PitNETs must be considered in differential diagnoses of sellar masses. Prompt and accurate diagnosis, coupled with a multidisciplinary treatment strategy, is essential. Our study contributes to the scarce literature on such metastases, providing a foundation for further understanding of this complex pathological entity.

Keywords: Collision tumors; PitNET; Pituitary adenomas; Prostate adenocarcinoma; Renal cell carcinoma; Tumor-to-tumor metastasis.

Publication types

  • Case Reports
  • Systematic Review

MeSH terms

  • Humans
  • Neoplasm Metastasis / pathology
  • Neuroendocrine Tumors* / pathology
  • Neuroendocrine Tumors* / secondary
  • Pituitary Neoplasms* / pathology
  • Pituitary Neoplasms* / secondary